Federal assistance awards · Assistance award

I-CORPS: COMMERCIALIZATION OF A REAL-TIME, PALM-SIZE, LOW-COST, AND WIRELESS SARS-COV-II DETECTOR -THE BROA…

Federal financial assistance recorded from USAspending. This is not a procurement contract.

Research this with AI

Research smarter with AI

Analyze opportunities and compare insights across leading AI models.

ASST_NON_2230853_049 · UNIVERSITY OF ARKANSAS · National Science Foundation

Compare Multiple AI Models with SmartSoloExplore CaptureIQ Intelligence

Assistance award details

Assistance award identifier
ASST_NON_2230853_049
FAIN
2230853
Recipient
UNIVERSITY OF ARKANSAS
Awarding agency
National Science Foundation
Funding agency
National Science Foundation
Assistance listing (CFDA)
47.084
Total obligated
$50,000
Period
Aug 1, 2022 – Jul 31, 2023
Fiscal year
2022
Place of performance state
AR
Source file
FY2022_All_Assistance_Full_20261006.zip

Description

I-CORPS: COMMERCIALIZATION OF A REAL-TIME, PALM-SIZE, LOW-COST, AND WIRELESS SARS-COV-II DETECTOR -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS I-CORPS PROJECT IS THE DEVELOPMENT OF A WIRELESS NANO-BIOSENSOR FOR DETECTION OF LIVE CORONAVIRUS PARTICLES AND POTENTIALLY OTHER PATHOGENS. CURRENTLY, A POSITIVE RESULT FROM AN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)- OR POLYMERASE CHAIN REACTION (PCR)-BASED COVID TEST DOES NOT DETERMINE IF THE CORONAVIRUS PARTICLES ARE LIVE (INFECTIOUS) OR DEAD (OR NEUTRALIZED OR NONINFECTIOUS). THE PROPOSED TECHNOLOGY IS DESIGNED TO DETECT INTERACTIONS OF LIVE CORONAVIRUS PARTICLES WITH TARGET CELLS, ANTIBODIES, AND DRUGS IN REAL-TIME. THOSE WITH A NEGATIVE RESULT FROM THE PROPOSED TECHNOLOGY HAVE CONFIRMATION THAT THEY ARE FREE OF LIVE, INFECTIOUS CORONAVIRUS PARTICLES AND WOULD NOT NEED TO QUARANTINE. THIS TECHNOLOGY MAY PROVIDE A TOOL FOR EFFECTIVELY COMBATTING THE COVID-19 VIRUS AND FUTURE PANDEMICS/EPIDEMICS AS WELL AS OTHER INFECTIONS. THIS I-CORPS PROJECT IS BASED ON THE DEVELOPMENT OF A NANO-BIOSENSING METHODOLOGY FOR PATHOGEN DETECTION INITIALLY FOCUSED ON SARS COV-II. THE PROPOSED TECHNOLOGY INTEGRATES A BIO-CERAMIC NANOWIRE/GRAPHENE CORE/SHELL NANOCOMPOSITE WITH A RADIO FREQUENCY IDENTIFICATION (RFID) TAG ON A WIRELESS COMMUNICATION CHIP SURFACE. THE HARDWARE OF THE NANO-BIOSENSING SYSTEM IS COMPOSED OF THREE PARTS: A RADIO FREQUENCY NANO-SENSOR, A RADIO FREQUENCY READER, AND A HANDHELD DEVICE OR SMART PHONE. THE PROPOSED NANO-BIOSENSOR IS MADE BY COATING THE BIOSAFE NANOCOMPOSITE ON A DISPOSABLE RFID TAG TO MAXIMIZE THE SENSITIVITY. FURTHER, NANO-BIOSENSORS MAY BE INTEGRATED TO SIMULTANEOUSLY DETECT SAMPLES IN A MULTI-WELL PLATE, WHICH IS VERSATILE AND EFFECTIVE IN THE DETECTION OF VIRUS PARTICLES, VIRAL ANTIGENS, AND ANTIBODIES, AS WELL AS IN EVALUATING VIRUS-NEUTRALIZING ANTIBODIES AND VACCINE EFFICACY. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDAT

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. Click Gemini to copy the research question when your browser allows, or use Copy question.